CHIMENTO, Adele
 Distribuzione geografica
Continente #
NA - Nord America 5.736
AS - Asia 4.566
EU - Europa 3.078
SA - Sud America 1.258
AF - Africa 300
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 14.965
Nazione #
US - Stati Uniti d'America 5.480
SG - Singapore 1.866
BR - Brasile 919
CN - Cina 823
UA - Ucraina 795
VN - Vietnam 766
DE - Germania 565
IT - Italia 534
AT - Austria 285
FR - Francia 231
BD - Bangladesh 217
SE - Svezia 216
IN - India 176
CA - Canada 138
FI - Finlandia 135
TR - Turchia 123
AR - Argentina 117
SN - Senegal 111
KR - Corea 93
HK - Hong Kong 92
GB - Regno Unito 78
IQ - Iraq 70
ZA - Sudafrica 68
MX - Messico 62
ID - Indonesia 58
PK - Pakistan 53
RU - Federazione Russa 53
EC - Ecuador 47
CO - Colombia 46
CL - Cile 40
MA - Marocco 38
NL - Olanda 38
BE - Belgio 32
VE - Venezuela 30
UZ - Uzbekistan 25
PY - Paraguay 20
AE - Emirati Arabi Uniti 19
JP - Giappone 19
PH - Filippine 18
SA - Arabia Saudita 18
ES - Italia 17
LT - Lituania 17
TN - Tunisia 17
MY - Malesia 16
PL - Polonia 16
AU - Australia 14
UY - Uruguay 14
DZ - Algeria 13
PE - Perù 13
EG - Egitto 12
EU - Europa 12
JO - Giordania 12
KE - Kenya 12
NP - Nepal 12
BO - Bolivia 10
OM - Oman 10
BH - Bahrain 9
AZ - Azerbaigian 8
CR - Costa Rica 8
ET - Etiopia 8
IE - Irlanda 8
IL - Israele 8
JM - Giamaica 8
PS - Palestinian Territory 8
AL - Albania 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
HN - Honduras 7
GE - Georgia 6
KZ - Kazakistan 6
PA - Panama 6
EE - Estonia 5
KG - Kirghizistan 5
LB - Libano 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
CH - Svizzera 4
MD - Moldavia 4
NG - Nigeria 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CG - Congo 3
CY - Cipro 3
GA - Gabon 3
HU - Ungheria 3
AM - Armenia 2
AO - Angola 2
BZ - Belize 2
CI - Costa d'Avorio 2
GT - Guatemala 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
Totale 14.939
Città #
Chandler 722
Singapore 722
Jacksonville 444
San Jose 428
Dallas 404
Ashburn 360
San Mateo 314
Boardman 285
Ho Chi Minh City 254
Beijing 228
New York 216
Dearborn 204
Rende 197
Vienna 191
Council Bluffs 186
Hanoi 159
Lawrence 116
Roxbury 114
Dakar 111
Lauterbourg 110
Shanghai 102
São Paulo 98
Helsinki 95
Seoul 93
Hong Kong 84
Izmir 81
Munich 76
Ottawa 74
Des Moines 72
Brooklyn 56
Cambridge 56
Hefei 56
Los Angeles 49
Turku 40
Da Nang 37
Bremen 35
Grafing 35
Frankfurt am Main 33
Haiphong 33
Orem 33
Wilmington 33
Brussels 32
Inglewood 32
Santa Clara 32
Ogden 31
Rio de Janeiro 28
Toronto 27
Baghdad 25
Columbus 25
Johannesburg 25
Guangzhou 24
Seattle 24
Tashkent 24
Ann Arbor 22
Pune 22
Hanover 21
London 21
Rome 21
Biên Hòa 20
Dhaka 20
The Dalles 20
Hải Dương 19
Cosenza 18
Guayaquil 18
Quito 18
Redwood City 18
San Francisco 18
Amsterdam 17
Jakarta 17
Mexico City 17
Belo Horizonte 16
Guarulhos 16
Milan 16
Santiago 16
Tianjin 16
Tokyo 16
Brasília 15
Chennai 15
Chicago 15
Florence 15
Lahore 15
Casablanca 13
Catanzaro 13
Fremont 13
Montevideo 13
Montreal 13
Mumbai 13
Falkenstein 12
Medellín 12
Salvador 12
Stockholm 12
Boston 11
Curitiba 11
Nairobi 11
Ninh Bình 11
Palermo 11
Porto Alegre 11
Wuhan 11
Amman 10
Cape Town 10
Totale 8.086
Nome #
6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS 262
6-substituted carbazoles: synthesis and biological evaluation 225
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 224
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 222
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment 215
27-hydroxycholesterol promotes adrenocortical cancer progression. 207
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines 194
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 193
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 192
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 191
Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: Part i 190
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 189
A phenylacetamide resveratrol derivative exerts inhibitory effects on breast cancer cell growth 189
Activation of G-Protein-Coupled Estrogen Receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 181
Activation of GPER induces apoptosis in adrenocortical cancer (ACC) cells and controls tumor growth in vivo 180
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment 179
Cholesterol as an endogenous ERRα agonist: A new perspective to cancer treatment 178
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line 177
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 173
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 172
17β-Estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ERα 171
A Resveratrol Phenylacetamide Derivative Perturbs the Cytoskeleton Dynamics Interfering with the Migration Potential in Breast Cancer 168
Cholesterol as new target for ACC therapy. 164
Antitumoral activities of curcumin and recent advances to improve its oral bioavailability 164
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 158
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 153
Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines 150
Inhibition of cholesterol synthesis by simvastatin reduces ACC growth interfering with the regulation of mitochondrial respiratory chain mediated by estrogens/estrogen receptor alpha. 150
Defining the pathway responsible for Leydig cell tumors: the role of IGF-I and estrogens. 149
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 148
The biochemical properties of the mitochondrial thiamine pyrophosphate carrier from Drosophila melanogaster 144
Antiproliferative effects of new N-alkylamino carbazole derivatives on breast cancer cell lines. 144
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 141
Antiproliferative effects of new carbazole derivative on breast cancer cell lines. 140
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 138
Role of GPER-Mediated Signaling in Testicular Functions and Tumorigenesis 138
Cyclooxygenase-2 (COX-2) inhibitors down-regulate aromatase expression and inhibit proliferation of tumor Leydig cells 137
Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells 137
SIRT1 is involved in adrenocortical cancer growth and motility 136
Cross-talk between estrogen and IGF-II signalling in adrenocortical tumor cell proliferation. 134
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 134
Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes 133
XCT790 an inverse agonist of estrogen related receptor alpha (ERRalpha) inhibits cellular metabolism, motility and invasion of adrenocortical cancer cell line H295R. 133
Retinoylation reaction of proteins in Leydig (TM-3) cells 132
Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers 132
Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment 129
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 126
Nandrolone and Stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation 126
Ruolo dei recettori nucleari orfani SF-1, LRH-1, SHP e DAX-1 nella regolazione dell’espressione dell'aromatasi in cellule testicolari 125
Effects of Atrazine on Estrogen Receptor α- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts 124
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer 124
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment 123
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 122
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new therapy for ACC 121
GPER Signaling in Spermatogenesis and Testicular Tumors 120
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol 120
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 119
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 118
Cross-talk between GPER and growth factor signaling 118
Potential of Olive oil Phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies 118
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression 115
Derivati 6,6A-Diidrofuro[3,2-b]furan-2-(5H)onici, loro preparazione e uso nel trattamento dei tumori 114
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to inhibit growth and invasion of adrenocortical carcinoma (ACC) Università della Calabria 113
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax 113
“Involment of orphan nuclear receptors SF-1, LRH-1, DAX-1 and SHP in regulation of aromatase expression in Leydig cells”. 113
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 112
Estrogen Related Receptor α (ERRα) As Potential Target for a New Adrenocortical Carcinoma (ACC) Therapy 111
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway 111
Involvment of Cyclooxygenase-2 (COX-2) in regulating estrogen-dependent Leydig cell tumor proliferation 109
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment 108
Characterization of olive flower phenolic extract (OFE) and its anti-proliferative activity on MCF-7 Human Breast Cancer Cells. 108
The metabolic regulator estrogen-related receptor alpha as a therapeutic target in Adrenocortical Carcinoma (ACC). 108
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells 107
Design, synthesis and biological evaluation of new 4-thiazolidinone derivatives in breast cancer cells. 107
Resveratrol, Epigallocatechin Gallate and Curcumin for Cancer Therapy: Challenges from Their Pro-Apoptotic Properties 105
Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line. 105
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 103
Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor leydig cell proliferation 102
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 102
Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance 101
Steroid Receptor Signaling as Targets for Resveratrol Actions in Breast and Prostate Cancer 101
G protein-coupled estrogen receptor-1 (GPER1)- and estrogen receptor α (ESR1)- dependent pathways regulate spermatocytes apoptosis. 101
Rapid estrogen signaling in spermatogenesis 100
Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression 100
C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines 99
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 98
L’attivazione selettiva di GPER inibisce la proliferazione e attiva l’apoptosi in cellule di Leydig tumorali. 97
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to fight adrenocortical carcinoma (ACC) progression and as useful tool to determine ACC stem cell-like proprieties. 97
Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse sertoli cell line, TM4 96
The Involvement of Natural Polyphenols in Molecular Mechanisms Inducing Apoptosis in Tumor Cells: A Promising Adjuvant in Cancer Therapy 95
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 95
Triiodothyronine (T3) decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line TM4 94
Role of scaffold protein Proline-, Glutamic acid-, and Leucine-Rich protein 1 (PELP1) in the modulation of adrenocortical cancer cell growth 94
Olea europaea L. Flowers as a new promising anticancer natural product: phenolic composition, antiproliferative activity and apoptosis induction 94
Role of IGF-I and estrogens in Leydig cell tumorogenesis. 93
Il tumore delle cellule del Leydig: il ruolo di IGF-I e degli estrogeni 92
The Estrogen Related Receptor α (ERRα) inverse agonist XCT-790 reduces adrenocortical cancer (ACC) H295R cells growth in vitro and in vivo. 92
GPR30 mediates estradiol-proliferative effects on GC-1 mouse spermatogonial cell line through ERK/Fos activation 91
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 91
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 91
Totale 13.472
Categoria #
all - tutte 82.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 0 77
2021/20221.485 5 223 10 82 193 40 10 340 15 14 171 382
2022/20231.722 210 234 119 199 221 144 7 185 210 54 73 66
2023/20241.066 117 46 67 60 65 286 41 40 70 49 38 187
2024/20252.165 150 280 63 123 167 105 72 125 388 184 215 293
2025/20266.583 749 240 710 531 1.199 452 716 354 518 498 311 305
Totale 15.172